Literature DB >> 15753546

ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.

D Allorge, R Hamdan, F Broly, C Libersa, J-F Colombel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15753546      PMCID： PMC1774451          DOI： 10.1136/gut.2004.055947

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  3 in total

1.  Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

Authors:  J F Colombel; N Ferrari; H Debuysere; P Marteau; J P Gendre; B Bonaz; J C Soulé; R Modigliani; Y Touze; P Catala; C Libersa; F Broly
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

2.  Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency.

Authors:  Satoshi Sumi; Anthony M Marinaki; Monica Arenas; Lynette Fairbanks; Monsor Shobowale-Bakre; David C Rees; Swee Lay Thein; Azhar Ansari; Jeremy Sanderson; Ronney A De Abreu; H Anne Simmonds; John A Duley
Journal:  Hum Genet       Date:  2002-08-15       Impact factor: 4.132

3.  Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).

Authors:  Anthony M Marinaki; Azhar Ansari; John A Duley; Monica Arenas; Satoshi Sumi; Cathryn M Lewis; El-Monsor Shobowale-Bakre; Emilia Escuredo; Lynette D Fairbanks; Jeremy D Sanderson
Journal:  Pharmacogenetics       Date:  2004-03
  3 in total
  15 in total

1.  Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.

Authors:  Gabriele Stocco; Eva Cuzzoni; Sara De Iudicibus; Diego Favretto; Noelia Malusà; Stefano Martelossi; Elena Pozzi; Paolo Lionetti; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  Do ITPA and TPMT genotypes predict the development of side effects to AZA?

Authors:  J A Duley; A M Marinaki; M Arenas; T H J Florin
Journal:  Gut       Date:  2006-07       Impact factor: 23.059

3.  Gene polymorphisms involved in manifestation of leucopenia, digestive intolerance, and pancreatitis in azathioprine-treated patients.

Authors:  Katerina Wroblova; Michal Kolorz; Marian Batovsky; Vladimir Zboril; Jana Suchankova; Milan Bartos; Boris Ulicny; Igor Pav; Ladislava Bartosova
Journal:  Dig Dis Sci       Date:  2012-04-26       Impact factor: 3.199

4.  Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?

Authors:  Luc J J Derijks; Daniel W Hommes
Journal:  Curr Gastroenterol Rep       Date:  2006-04

Review 5.  Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia.

Authors:  Tiphaine Adam de Beaumais; Evelyne Jacqz-Aigrain
Journal:  Eur J Clin Pharmacol       Date:  2012-03-16       Impact factor: 2.953

Review 6.  Pharmacogenetics in inflammatory bowel disease.

Authors:  Marie Pierik; Paul Rutgeerts; Robert Vlietinck; Severine Vermeire
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

7.  The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.

Authors:  Hiromistu Ban; Akira Andoh; Hirotsugu Imaeda; Ayako Kobori; Shigeki Bamba; Tomoyuki Tsujikawa; Masaya Sasaki; Yasuharu Saito; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2010-10       Impact factor: 7.527

8.  Accuracy of genotyping using the TaqMan PCR assay for single nucleotide polymorphisms responsible for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.

Authors:  Rie Osaki; Hirotsugu Imaeda; Hiromitsu Ban; Tomoki Aomatsu; Shigeki Bamba; Tomoyuki Tsujikawa; Masaya Sasaki; Yoshihide Fujiyama; Akira Andoh
Journal:  Exp Ther Med       Date:  2011-06-16       Impact factor: 2.447

9.  Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.

Authors:  Ahmed F Hawwa; Jeff S Millership; Paul S Collier; Koen Vandenbroeck; Anthony McCarthy; Sid Dempsey; Carole Cairns; John Collins; Colin Rodgers; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

10.  NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease.

Authors:  Ayumi Asada; Atsushi Nishida; Makoto Shioya; Hirotsugu Imaeda; Osamu Inatomi; Shigeki Bamba; Katsuyuki Kito; Mitsushige Sugimoto; Akira Andoh
Journal:  J Gastroenterol       Date:  2015-11-21       Impact factor: 7.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.